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Abstract
Background: Chronic rheumatic diseases are painful conditions which are not entirely
controllable and can place high emotional demands on individuals. Increasing evidence has shown
that emotion regulation in terms of actively processing and expressing disease-related emotions are
likely to promote positive adjustment in patients with chronic diseases. The Emotional Approach
Coping Scale (EAC) measures active attempts to acknowledge, understand, and express emotions.
Although tested in other clinical samples, the EAC has not been validated for patients with
rheumatic diseases. This study evaluated the data quality, internal consistency reliability, validity and
responsiveness of the Norwegian version of the EAC for this group of patients.
Methods: 220 patients with different rheumatic diseases were included in a cross-sectional study
in which data quality and internal consistency were assessed. Construct validity was assessed
through comparisons with the Brief Approach/Avoidance Coping Questionnaire (BACQ) and the
General Health Questionnaire (GHQ-20). Responsiveness was tested in a longitudinal pretest-
posttest study of two different coping interventions, the Vitality Training Program (VTP) and a Self-
Management Program (SMP).
Results: The EAC had low levels of missing data. Results from principal component analysis
supported two subscales, Emotional Expression and Emotional Processing, which had high
Cronbach's alphas of 0.90 and 0.92, respectively. The EAC had correlations with approach-oriented
items in the BACQ in the range 0.17-0.50. The EAC Expression scale had a significant negative
correlation with the GHQ-20 of -0.13. As hypothesized, participation in the VTP significantly
improved EAC scores, indicating responsiveness to change.
Conclusion: The EAC is an acceptable and valid instrument for measuring emotional processing
and expression in patients with rheumatic diseases. The EAC scales were responsive to change in
an intervention designed to promote emotion regulation. The instrument has not yet been tested
for test-retest reliability, which is recommended in future studies.
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Chronic rheumatic diseases often have an important
impact on physical, as well as psychological and social
aspects of patients' lives. Such long-term stressors that
have uncontrollable elements can place great emotional
demands on the individual. Research has documented a
high degree of depression, anxiety and psychological dis-
tress in patients with rheumatoid arthritis (RA) and other
rheumatic diseases [1-6].
There are individual differences in how patients cope with
various symptoms and adjust to the burden of the disease.
In early stages of the disease emotional distress is associ-
ated with levels of pain and fatigue, functional status, dis-
ease impact on daily life, life events and perceived social
support [1,7]. The effect of disease-related factors on psy-
chological distress seems to decrease [3,8] and personality
characteristics and individual coping resources appear to
become more important predictors over time [7,9]. Vari-
ous self-management interventions have been developed
to improve patients' ability to cope with the complexity of
symptoms related to their rheumatic disease [10-12].
There is a growing consensus that emotion regulation, in
terms of acknowledging and dealing with negative emo-
tions associated with chronic illness, can contribute to
adjustment [13,14]. However, few interventions explicitly
address patients' emotional response to their disease
[9,15].
The Vitality Training Program (VTP) is a Norwegian group
intervention [16], which has a special focus on awareness
of and reflection upon one's own emotions, thoughts and
bodily experiences. It has produced a reduction in psycho-
logical distress and increased emotional well-being in a
randomized, controlled trial in persons with chronic mus-
culoskeletal pain [17] and in a one-year follow-up of a
non-controlled study for patients with inflammatory
rheumatic diseases [18]. The results shall be further evalu-
ated in a randomized, controlled trial. However, follow-
ing a search of the literature, no acceptable instrument to
measure intervention-related change in patients' coping
strategies related to emotional awareness was found.
The coping literature makes a distinction between prob-
lem-focused and emotion-focused coping strategies [19-
21]. Problem-focused coping includes direct efforts to
alter the demands on the person, whereas emotion-
focused coping includes efforts to regulate emotions asso-
ciated with stressful situations. Research based on earlier
published coping scales has found that use of emotion-
focused coping strategies is often associated with psycho-
logical distress and maladjustment [13,20,22]. However,
there is increasing research on the adaptive nature of
acknowledging, processing, and expressing one's emo-
tions. An ability to approach one's and others' emotions
is seen as crucial to healthy intra- and interpersonal func-
tioning [13-15,23]. This view has also received empirical
support through studies on emotional disclosure inter-
ventions [24-29].
Major problems have been identified in the existing con-
ceptualization and measurement of emotion-focused cop-
ing [13,20,22]. Diverse coping methods, such as
approach-oriented (e.g. seeking social support) and avoid-
ance-oriented (e.g. denial) strategies, have been assessed
with emotion-focused coping items, some of which are
inversely correlated. Emotion-focused coping scales have
also included items related to emotional distress and neg-
ative emotions (e.g. angry, upset, blame myself). Hence,
these earlier measures of emotion-focused coping were
confounded by aspects of psychological health. Stanton et
al [22] developed a construct of emotional approach cop-
ing which does not include distress-related items. Based
on this construct, the Emotional Approach Coping Scale
(EAC) is comprised of two factors [22]: Emotional
Processing, which includes active attempts to acknowl-
edge, explore meanings and come to an understanding of
one's emotions; and Emotional Expression, which
includes active verbal and/or nonverbal attempts to com-
municate or symbolize one's emotional experience. The
EAC has been tested in clinical samples [13], including
patients with chronic myofascial pain [29]. These studies
show that emotional approach coping is inversely related
to psychological distress and can predict better adjust-
ment and less pain and depression over time [13,22,29].
The aim of this study was to evaluate the Norwegian ver-
sion of the EAC in patients with rheumatic diseases. More
specifically, the instrument was tested for data quality,
internal consistency reliability and construct validity in a
cross-sectional study. Responsiveness to change was
assessed using longitudinal data from a pretest-posttest
study that included patients recruited from two different
coping interventions, the VTP and an inpatient Self-Man-
agement Program (SMP).
Methods
Data collection
Recruitment of three different groups of patients took
place in 2007 and all received self-completed question-
naires. For the cross-sectional study, 118 consecutive
patients (group 1) who had a confirmed rheumatological
diagnosis and who attended regular consultations at rheu-
matology inpatient, outpatient or day hospital clinics,
were recruited. Questionnaires were given to patients by
rheumatology nurses at a single data collection point. For
the pretest-posttest study, 49 patients (group 2) attending
four VTP groups and 103 patients (group 3) attending five
diagnosis-specific SMP courses were recruited. Group 2
were given questionnaires by facilitators immediatelyPage 2 of 9
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naires after the last session. Group 3 were given the ques-
tionnaires by a nurse at the beginning of the first day of
the SMP and at the end of the last day of the course. Base-
line data from group 2 and 3 and all data from group 1
were used in the cross-sectional study.
Inclusion criteria were adults with confirmed rheumato-
logical diagnosis in the consecutive sample (group 1) and
confirmed rheumatological diagnosis of at least six
months duration and age over 20 years in the two coping
interventions (group 2 and 3). All patients received writ-
ten and oral information regarding the study, and
informed consent was obtained from all patients before
entering the study. Group 1 patients were free to either fill
out the questionnaire or not; questionnaires were sent
back anonymously. This survey was regarded as a compo-
nent of quality assurance and hence ethical approval was
not required. The pretest-posttest study samples partici-
pated in two evaluation studies, which both were
approved by the Regional Committee for Medical Ethics.
Interventions
The VTP aims at helping patients to become more aware
of their internal and external resources in order to cope
with their current life situation. Processing, acknowledg-
ing, and expressing one's emotions are central elements.
Through participation-based teaching and counselling
methods, as well as awareness and relaxation training,
patients learn to accept their thoughts, feelings and bodily
experiences as they are, and respond to their symptoms,
other people, and situations in more adaptive ways. The
VTP lasts for approximately 4 months, involving 10 ses-
sions of process-oriented group learning for 8 to 12
patients with different rheumatic diseases. Each group is
facilitated by two health professionals (nurses, physio-
therapists, occupational therapists or social workers), who
have completed a one-year postgraduate program in the
VTP. The one-week inpatient Self-Management Program
(SMP) is taught in disease specific groups for 16 patients,
consisting of consultation with a rheumatologist, multi-
disciplinary disease specific teaching, physical exercises
and sharing experiences in small groups. The aim of this
intervention is to strengthen the patients' ability to man-
age symptoms, treatment, and physical and psychosocial
life style changes inherent in living with a rheumatic dis-
ease.
Measures
The EAC comprises 16 items that form two subscales;
Emotional Processing (8 items) and Emotional Expres-
sion (8 items). The items have a 4-point scale of "I don't
do this at all", "I do this a little bit", "I do this a medium
amount" and "I do this a lot". The mean item score is cal-
culated for each subscale. The two subscales have satisfac-
tory internal consistency and test-retest reliability in
samples of undergraduate students [22].
The original US version of the EAC underwent a forward
and backward translation [30]. Two Norwegians profi-
cient in English independently translated the question-
naire into Norwegian. One licensed translator, and a
person who was proficient in English carried out the back-
ward translation independently. The forward and back-
ward translations were discussed by the translators, a
psychologist and the research group. Discrepancies
between the various versions were resolved by consensus
in order to achieve conceptual equivalence between the
Norwegian and original US versions of the EAC. The con-
sensus version of the back-translation was mailed to the
original author (ALS) who confirmed semantic equiva-
lence. In the current study, participants were instructed to
complete the items with reference to how they usually
respond to emotions related to their chronic rheumatic
disease.
The Brief Approach/Avoidance Coping Questionnaire
(BACQ) comprises 12 items designed to measure a gen-
eral concept of approach-versus avoidance-oriented cop-
ing. Items have a 5-point Likert scale from "strongly
disagree" to "strongly agree". The BACQ had satisfactory
psychometric properties in a Norwegian population of
primary care patients [31].
The General Health Questionnaire (GHQ-20) comprises
20 items and measures several aspects of psychological
distress during the previous 2 weeks [32,33]. Items have a
4-point scale of "not at all", "no more than usual", "rather
more than usual" and "much more than usual". The total
score ranges from (0) no distress at all to (60) severe dis-
tress. The GHQ has been shown to be valid and reliable
across cultures [34] and the GHQ-20 has been widely
used in Norwegian studies [35,36].
Statistical analyses
Levels of missing data were assessed for the EAC items and
scales. Evidence for the existence of the two EAC subscales
was assessed by principal component analyses (PCA) with
varimax rotation [37]. Components with eigenvalues
greater than one were considered potentially important.
Internal consistency
Internal consistency was assessed by item-total correla-
tions and Cronbach's alpha. For a scale to be sufficiently
reliable for use in groups of patients, an alpha value of
0.70 is considered acceptable [38,39].
Construct validity
Construct validity was assessed by comparing the EAC
scores with the BACQ and GHQ-20 with Pearson's corre-Page 3 of 9
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scores would be positively related to approach-oriented
items in the BACQ. EAC subscales and the BACQ measure
distinct aspects of coping, and hence correlations with the
BACQ were not expected to be high, but of a low to mod-
erate level (0.3 - 0.6). Because the EAC scales were
designed to be unconfounded by distress-laden content
[22], we expected the correlations with GHQ-20 to be
negative and of a low magnitude under 0.3.
Responsiveness to change
Responsiveness refers to an instrument's ability to meas-
ure change over time [39,42,43]. This was assessed in the
VTP and the SMP samples by the standardized response
mean (SRM). SRMs were calculated by dividing the mean
change scores by the standard deviation (SD) of the
change scores. Effective processing and expression of emo-
tions are more central elements in the VTP than in the
SMP, and hence it was hypothesised that relative to SMP
participants, the VTP participants would have a larger
increase in the EAC scores.
All analyses were performed with SPSS, version 14.0
(SPSS Inc., Chicago, IL, USA).
Results
Data collection
A total of 220 patients were included in the cross-sectional
study; 118 in group 1, 66 (64.1%) in group 2 and 36
(73.5%) in group 3 (table 1). Patients had a mean age of
50.3 (SD 12.63), 165 (75.0%) were women and following
diagnoses were reported: rheumatoid arthritis (58), anky-
losing spondylitis (38), psoriatic arthritis (32), fibromyal-
gia (31), osteoarthritis (25), connective tissue diseases
(11), juvenile rheumatoid arthritis (4) and others (18).
Group 1 patients attending the rheumatology clinic were
more likely to be men and had significantly longer disease
duration than the two others. Group 3 patients attending
the VTP, were significantly younger than the two other
groups. No significant differences were found for other
variables assessed at baseline (table 1).
Statistical analyis
Overall, patients were able to complete the EAC question-
naire without help. There were few missing values, and
these ranged from 1.9% to 5.7% for items relating to Emo-
tional Expression and Emotional Processing, respectively.
Mean item scores (SD) ranged from 2.51 (0.89) to 3.32
(0.66) (table 2).
Principal component analysis yielded two components
with eigenvalues 7.25 and 2.79; a third weak component
had an eigenvalue of 0.97. The first two components
accounted for 62.7% of the total variance. Both compo-
nents had high loadings, the majority (14/16) being over
0.6 and clearly reflecting the two hypothesized domains
of Emotional Expression and Emotional Processing.
Internal consistency
Item-total correlations all exceeded 0.45. Both the EAC
Expression and Processing scales met the Cronbach's
alpha criterion of 0.70.
There were very little missing data at the scale level. Whilst
item scores were generally skewed towards positive levels
of coping, the domain scores were more normally distrib-
uted with means of 2.84 (0.63) and 2.71 (0.63) for Emo-
tional Processing and Emotional Expression, respectively
(table 2). End effects were low; 3 (1.36%); and 0 patients
scored at the floor and 10 (4.55%) and 14 (6.36%) scored
at the ceiling for Emotional Expression and Emotional
Processing, respectively.
Construct validity
As hypothesised the EAC scales had low to moderate cor-
relations with the approach-oriented items in the BACQ.
The EAC Expression scale had significant moderate corre-
lations with the BACQ items "I say so if I am angry or sad"
and "I like to talk to a few chosen people when things get
too much for me", but had only weak correlations with
the other approach-oriented items. The EAC Processing
scale had a significant moderate correlation with the item
"I like to talk to a few chosen people when things get too
much for me" and was only weakly correlated with the
other approach-oriented items (table 3). There were no
significant correlations between the EAC scales and the
avoidance-oriented items in BACQ. The EAC Expression
scale had a low, but significant, negative correlation with
the GHQ-20, such that higher emotional expression was
associated with lower distress, supporting the hypothesis
that the EAC scales are unconfounded of distress-laden
content. The correlation between the EAC Processing scale
and the GHQ-20 was very low and not significant.
Responsiveness to change
Twenty-six (72%) of the included patients in group 2
completed a questionnaire after the VTP. All included
group 3 patients attending the SMP completed a question-
naire after the program. As hypothesised the EAC scores
increased more in the VTP sample than in the SMP sam-
ple. In the VTP sample, there were significant increases in
both EAC Processing and EAC Expression. This group also
showed a significant reduction in GHQ-20 scores. The
SRMs were between 0.40 and 0.73. There were no signifi-
cant changes in the EAC scales in the SMP sample at fol-
low-up, but a significant reduction was found in the
GHQ-20 scores (table 4).
Discussion
This study has translated the EAC to Norwegian following
established guidelines for forward-backwards translationPage 4 of 9
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acceptable to patients with rheumatic diseases and had
low levels of missing data. The results of PCA show that
the two scales defined by the instrument's authors are sup-
ported empirically. The EAC scales also have good evi-
dence for internal consistency and construct validity. As
hypothesized, the EAC scales were responsive to change in
an intervention designed to promote effective emotion
regulation (VTP), but not in an intervention with less
focus on managing emotions (SMP).
The items "I realize that my feelings are valid and impor-
tant" and "I acknowledge my emotions" had the lowest
item-total correlations. The content of these two items
may be interpreted as reflecting the value of one's emo-
tions. They loaded satisfactorily on the emotional process-
Table 1: Baseline characteristics of patients (n = 220)
Group 1 Group 2 Group 3
Rheumatology Vitality Training Self-Management
clinics (n = 118) Program (n = 36) Program (n = 66)
Age, mean (range) 49.9 (17 - 78) 45.9 (29 - 71)* 53.3 (25 - 86)
Female, n(%) 71 (60.7)** 34 (94.4) 60 (90.9)
Disease duration, mean (range) 10.0 (0 - 47)*** 5.0 (1 - 45) 5.0 (0.5 - 32)
Diagnosis, n (%):
rheumatoid arthritis 48 (41.7) 10 (27.8) 0
ankylosing spondylitis 22 (19.1) 6 (16.7) 19 (15.2)
psoriatic arthritis 20 (17.4) 5 (13.9) 7 (10.6)
fibromyalgia 2 (1.7) 8 (22.2) 21 (31.8)
connective tissue disease 5 (4.3) 0 6 (9.1)
osteoarthritis 1 (0.9) 2 (5.6) 22 (33.3)
juvenile arthritis 3 (2.6) 1 (2.8) 0
others 14 (12.2) 4 (11.1) 0
EACscales:
Emotional Processing 2.78 (0.6) 2.96 (0.6) 2.83 (0.7)
Emotional Expression 2.68 (0.6) 2.60 (0.7) 2.76 (0.6)
BACQ 3.28 (0.4) 3.25 (0.5) 3.15 (0.4)
GHQ - 20 22.01 (9.8) 24.06 (7.8) 22.48 (9.6)
Emotional Processing: 1 = low processing, 4 = high processing
Emotional Expression: 1 = low expression, 4 = high expression
BACQ = Brief Approach/Avoidance Coping Questionnaire: 1 = low approach, 4 = high approach
GHQ - 20 = General Health Questionnaire: 0 = no distress, 60 = high distress
Values are means (SD) for continues variables and frequencies (percentages within sample) for categorical values.
Disease duration = median years since diagnosis.
* significant lower mean than the two other samples (p = 0.027)
** significant lower proportion than the two other samples (p < 0.001)
*** significant higher median than the two other samples (p < 0.001)Page 5 of 9
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2009, 10:107 http://www.biomedcentral.com/1471-2474/10/107ing factor, but might as well have contributed to a third
factor. Looking at the skewed distributions of these two
items, we also found a ceiling effect, which may reflect a
high threshold for saying that one's emotions are not
valid and acknowledged. There were some missing values
for these items, and hence they may have been more diffi-
cult to interpret for some patients.
Both EAC scales have high internal consistency which fol-
low previous findings [22,29]. The high Cronbach's alpha
for the EAC Expression scale (0.92) may indicate that
some of the items in this scale are unnecessary. An earlier
version of the EAC comprised two four-item scales [22]
which were expanded to eight-item scales. The longer ver-
sion was found to have slightly higher reliability, which
was the reason for choosing the longer-form version for
this cross-cultural adaptation. If the EAC is to be used with
groups of patients, then it might be argued that the four-
item scales will suffice. However, if the instrument is to be
used in clinical practice for assessing individual patients
then the longer-form is recommended since it meets the
minimum criterion of a Cronbach's alpha of 0.90 [44].
Both EAC scales were related to the approach-oriented
items in the BACQ and uncorrelated with the avoidance-
oriented items, supporting construct validity. As expected,
the correlations were strongest between EAC Expression
and the expressive BACQ items. The inverse correlation
between EAC Expression and the GHQ-20 scores supports
the hypothesis that EAC Expression is related to positive
adjustment, rather than dysfunction. From the negative
correlation it may be concluded that the concept of coping
through expressing one's emotions is distinct from psy-
chological distress. Taken together, these findings corre-
spond with previous studies that concluded that
emotional approach coping is conceptually different from
Table 2: Descriptive statistics, component loadings and internal consistency of the EAC (n = 220)
Frequency %
Scale/item Missing (%) Mean (SD) Not at all A little Moderately A lot Component 
loadinga
Cronbach's 
α/item-total 
correlation
Emotional 
processingb
2.84 (0.63) - - - - - 0.90
Take time to figure 
out
1 (0.5) 2.79 (0.77) 8 (3.6) 73 (33.2) 100 (45.5) 38 (17.3) 0.71 0.88
Delve into feelings 0 2.62 (0.83) 14 (6.4) 92 (41.8) 79 (35.9) 35 (15.9) 0.81 0.88
Validity/
importance
3 (1.4) 3.28 (0.69) 6 (2.7) 17 (7.7) 105 (47.7) 89 (40.5) 0.58 0.90
Acknowledge 
emotions
5 (2.4) 3.32 (0.66) 0 25 (11.4) 96 (43.6) 94 (42.7) 0.46 0.90
Work on 
understanding
0 2.88 (0.84) 11 (5.0) 64 (29.1) 87 (39.5) 58 (26.4) 0.84 0.88
Explore emotions 2 (0.9) 2.51 (0.89) 30 (13.6) 85 (38.6) 72 (32.7) 31 (14.1) 0.80 0.88
Find way to 
understand
1 (0.5) 2.69 (0.84) 15 (6.8) 82 (37.3) 84 (38.2) 38 (17.3) 0.80 0.88
Look closely at 
reasons
0 2.72 (0.91) 20 (9.1) 72 (32.7) 79 (35.9) 49 (22.3) 0.85 0.88
Emotional 
expressionb
2.71 (0.63) - - - - - 0.92
Take time to 
express
0 2.62 (0.76) 10 (4.5) 89 (40.5) 94 (42.7) 27 (12.3) 0.62 0.91
Let feelings come 
out
0 2.57 (0.84) 21 (9.5) 84 (38.2) 87 (39.5) 28 (12.7) 0.79 0.91
Allow myself to 
express
0 2.75 (0.81) 14 (6.4) 62 (28.2) 110 (50.0) 34 (15.5) 0.85 0.90
Feel free to 
express
0 2.92 (0.84) 15 (6.8) 45 (20.5) 109 (49.5) 51 (23.2) 0.75 0.91
Express feelings I 
have
1 (0.5) 2.77 (0.74) 8 (3.6) 66 (30.0) 113 (51.4) 32 (14.5) 0.86 0.90
Find way to 
express
2 (0.9) 2.80 (0.72) 8 (3.6) 58 (26.4) 122 (55.5) 30 (13.6) 0.62 0.92
Let feelings out 0 2.65 (0.82) 16 (7.3) 85 (38.6) 88 (40.0) 31 (14.1) 0.87 0.90
Get feelings out 1 (0.5) 2.67 (0.77) 13 (5.9) 80 (36.4) 100 (45.5) 26 (11.8) 0.82 0.90
a Emotional expression and emotional processing had eigenvalues of 7.25 and 2.79 respectively
b The two EAC scales are scored from 1-4 where 4 reflects the most frequent use of EACPage 6 of 9
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Table 3: Correlation between the EAC scores, BACQ and GHQ-20 (n = 220)
EAC processing EAC expression
EAC processing - 0.48**
EAC expression 0.48** -
BACQ total 0.29** 0.40**
1 I say so if I am angry or sad 0.18* 0.50**
2 I like to talk to a few chosen people when things get too much for me 0.39** 0.44**
4 I make an active effort to find a solution to my problems 0.26** 0.17*
8 I think something positive could come out of my complaints/problems 0.24** 0.22**
9 I firmly will believe that my problems will decrease 0.08 0.13*
GHQ-20 - 0.01 -0.21*
* p < 0.05, ** p < 0.01
Table 4: Responsiveness of the EAC, BACQ and GHQ-20 in the VTP§ (n = 26) and the SMP§ (n = 66)
Baseline Follow-up Change scores SRM
mean (SD) mean (SD) mean (SD)
EAC processing
VTP (4 months) 3.12 (0.60) 3.39 (0.64) - 0.27 (0.58)* 0.47
SMP (1 week) 2.83 (0.66) 2.93 (0.66) - 0.10 (0.52) 0.19
EAC expression
VTP (4 months) 2.69 (0.64) 3.06 (0.56) - 0.37 (0.53)** 0.70
SMP (1 week) 2.76 (0.63) 2.82 (0.57) - 0.06 (0.45) 0.13
BACQ total
VTP (4 months) 3.41 (0.42) 3.55 (0.46) - 0.14 (0.35) 0.40
SMP (1 week) 3.14 (0.44) 3.22 (0.45) - 0.08 (0.36) 0.22
GHQ-20
VTP (4 months) 24.88 (9.40) 16.23 (9.33) 8.65 (11.80)** 0.73
SMP (1 week) 22.94 (9.96) 17.55 (8.89) 5.39 (7.15)** 0.75
§ VTP = the Vitality Training Program, SMP = the Self Mangement Program
* P < 0.05, ** P < 0.001, Values refer to statistical differences in mean scores between T1 and T2
SD = Standard deviation
SRM = Standardized Response Mean
BMC Musculoskeletal Disorders 2009, 10:107 http://www.biomedcentral.com/1471-2474/10/107passive, avoidance-oriented coping and from other emo-
tion-focused coping strategies related to distress [22,29].
The findings supported the hypothesis that patients with
rheumatic diseases participating in the VTP would
increase their EAC, whereas participants in the SMP would
not. The two interventions are different in both length
and content. In the SMP, active problem-focused coping
strategies are emphasized. Even though emotional distress
is a topic in the program, the participants are not invited
to explore and understand their own emotional coping
strategies to the same degree as in the VTP. Therefore it
was not expected that this one-week program would
change emotion-focused coping strategies. In contrast, the
VTP is a four-month process-oriented program with a spe-
cial focus on emotions, and hence a change in emotion-
focused coping strategies was expected. Both EAC scale
scores improved significantly after the VTP. The smaller,
significant change in EAC Processing may be due to the
relatively high score at baseline, making it difficult to
detect change. There were also a small number of patients
in the VTP sample so the results should be interpreted
with some caution. Few studies have examined EAC as an
outcome or moderator of effects of emotion regulation
interventions [22,28,45-48]. Findings in this study indi-
cate that the EAC may be used as an outcome measure in
interventions for patients with rheumatic diseases where
emotional approach coping is targeted.
A limitation in this study is that the EAC was compared
with only two other measures to assess construct validity
and comparisons with other scales measuring approach/
avoidance-oriented coping and active/passive coping are
recommended. Another limitation is that the instrument
has not yet been tested for test-retest reliability, which is
recommended in future studies. Test-retest data would
also have allowed the calculation of the responsiveness
statistic, which takes account of score variation in patients
who are stable [49]. Receiver operating characteristic
(ROC) curves [50] is a further method of assessing respon-
siveness but the absence of a criterion relating to whether
patients had an important improvement in coping limited
the scope for ROC analysis in this study. The identifica-
tion of patients that have had an important change in
their coping based on clinical or patient judgments can
also facilitate the interpretability of EAC subscale scores
[38]. The short follow-up period in the pretest-posttest
study is a further study limitation, which limits the con-
clusions relating to responsiveness.
Conclusion
The results of this study show that the EAC has evidence
for data quality, internal consistency and validity, but has
yet to be assessed for test-retest reliability, which is recom-
mended in future studies. The study has also shown that
participation in the VTP improves emotion-focused cop-
ing strategies as measured by the EAC in patients with var-
ious rheumatic diseases, showing that the EAC scales are
responsive to change. Further studies based on larger sam-
ples with a longer follow-up period that include other
important psychological and health-related outcome
measures are recommended.
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